Clinical Trial

Tumor-Lymph Node Mapping

Study acronym: T-LyM
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-02; most recent amendment 2026-04-20.
Status change: Not Yet Recruiting → Recruiting 2026-04-20
Trial Details
NCT Number NCT07054944
Lead Sponsor University of Rochester
Conditions Pediatric Solid Tumors, Rhabdomyosarcoma, Sarcoma, Germ Cell Tumor
Enrollment 10 participants
Start Date 2026-04-13
Primary Completion 2028-07-30 (estimated)
Study Completion 2028-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-23